Transgene Biotek Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|
| Revenue | 0.70 | 0.10 | 0.09 |
| Operating Expense | 0.46 | 0.31 | 0.15 |
| Net Profit | 0.20 | -0.27 | -0.12 |
| Net Profit Margin | 28.57 | -270 | -133.33 |
| Earning Per Share | 0.03 | -0.04 | -0.02 |
| EBIDTA | 0.24 | -0.22 | -0.07 |
| Effective Tax Rate | TBA | TBA | TBA |
| Particulars | Jun 2024 |
|---|---|
| Revenue | 0.70 |
| Operating Expense | 0.46 |
| Net Profit | 0.20 |
| Net Profit Margin | 28.57 |
| Earning Per Share | 0.03 |
| EBIDTA | 0.24 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|
| Total Revenue Annual | 0.06 | 0.09 | 0.17 |
| Operating Expenses Annual | 1.11 | 0.55 | 0.70 |
| Operating Profit Annual | -0.88 | -0.25 | -0.26 |
| Interest Annual | 0.18 | 0.23 | 0.27 |
| Depreciation | 0.09 | 0.18 | 0.20 |
| Net Profit Annual | -6.01 | -10.40 | -10.43 |
| Tax Annual | TBA | TBA | TBA |
| Particulars | Mar 2023 |
|---|---|
| Total Revenue Annual | 0.06 |
| Operating Expenses Annual | 1.11 |
| Operating Profit Annual | -0.88 |
| Interest Annual | 0.18 |
| Depreciation | 0.09 |
| Net Profit Annual | -6.01 |
| Tax Annual | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.02 | 0.01 | 0.04 |
| Cash Flow from Operations | TBA | 0.10 | 0.01 |
| Cash Flow from Investing | -0.01 | -0.10 | -0.04 |
| Cash Flow from Financing | TBA | TBA | TBA |
| Cash Flow at the End | TBA | 0.02 | 0.01 |
| Particulars | Mar 2023 |
|---|---|
| Cash Flow at the Beginning | 0.02 |
| Cash Flow from Operations | TBA |
| Cash Flow from Investing | -0.01 |
| Cash Flow from Financing | TBA |
| Cash Flow at the End | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|
| PBDIT Margin (%) | -733.33 | -277.78 | -152.94 |
| PBIT Margin (%) | -8,983.33 | -11,300 | -5,982.35 |
| PBT Margin (%) | 5,500.00 | 37,833.33 | 16,152.94 |
| Net PROFIT Margin (%) | -10,016.67 | -11,555.56 | -6,135.29 |
| Return On Networth / Equity (%) | TBA | TBA | TBA |
| Return On Networth /Employed (%) | TBA | TBA | TBA |
| Return On Assets (%) | TBA | TBA | TBA |
| Total Debt / Equity (X) | TBA | 5.23 | 1.10 |
| Asset Turnover Ratio (%) | TBA | TBA | TBA |
| Particulars | Mar 2023 |
|---|---|
| PBDIT Margin (%) | -733.33 |
| PBIT Margin (%) | -8,983.33 |
| PBT Margin (%) | 5,500.00 |
| Net PROFIT Margin (%) | -10,016.67 |
| Return On Networth / Equity (%) | TBA |
| Return On Networth /Employed (%) | TBA |
| Return On Assets (%) | TBA |
| Total Debt / Equity (X) | TBA |
| Asset Turnover Ratio (%) | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|
| Fixed Assets Annual | 8.32 | 13.26 | 23.19 |
| Total Current Assets Annual | 0.89 | 0.69 | 0.64 |
| Non Current Assets Annual | 31.59 | 36.53 | 46.36 |
| Total Shareholders Funds Annual | -6.21 | -0.20 | 4.66 |
| Total Assets Annual | 32.48 | 37.22 | 46.99 |
| Particulars | Mar 2023 |
|---|---|
| Fixed Assets Annual | 8.32 |
| Total Current Assets Annual | 0.89 |
| Non Current Assets Annual | 31.59 |
| Total Shareholders Funds Annual | -6.21 |
| Total Assets Annual | 32.48 |
EPS (INR)
Expected
0.03
Reported
0.03
Surprise
0.00%
Mar 2024
EPS beaten by 0.00%
Dec 2023
EPS beaten by 0.00%
Sep 2023
EPS beaten by 0.00%
